abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile
Saved in:
| Title: | abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile |
|---|---|
| Authors: | Kereiakes, Dean J.1 lindner@fuse.net, Lincoff, A.Michael2, Anderson, Keaven M.3, Achenbach, Robert3, Patel, Kamlesh3, Barnathan, Elliot3, Califf, Robert M.4, Topol, Eric J.2, EPIC Investigators (CORPORATE AUTHOR), EPILOG investigators (CORPORATE AUTHOR), EPISTENT investigators (CORPORATE AUTHOR) |
| Source: | American Journal of Cardiology. Sep2002, Vol. 90 Issue 6, p628-630. 3p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 7875014 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Kereiakes%2C+Dean+J%2E%22">Kereiakes, Dean J.</searchLink><relatesTo>1</relatesTo><i> lindner@fuse.net</i><br /><searchLink fieldCode="AR" term="%22Lincoff%2C+A%2EMichael%22">Lincoff, A.Michael</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Anderson%2C+Keaven+M%2E%22">Anderson, Keaven M.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Achenbach%2C+Robert%22">Achenbach, Robert</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Patel%2C+Kamlesh%22">Patel, Kamlesh</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Barnathan%2C+Elliot%22">Barnathan, Elliot</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Califf%2C+Robert+M%2E%22">Califf, Robert M.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Topol%2C+Eric+J%2E%22">Topol, Eric J.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22EPIC+Investigators%22">EPIC Investigators</searchLink> (CORPORATE AUTHOR)<br /><searchLink fieldCode="AR" term="%22EPILOG+investigators%22">EPILOG investigators</searchLink> (CORPORATE AUTHOR)<br /><searchLink fieldCode="AR" term="%22EPISTENT+investigators%22">EPISTENT investigators</searchLink> (CORPORATE AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22American+Journal+of+Cardiology%22">American Journal of Cardiology</searchLink>. Sep2002, Vol. 90 Issue 6, p628-630. 3p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=7875014 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0002-9149(02)02568-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 3 StartPage: 628 Titles: – TitleFull: abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kereiakes, Dean J. – PersonEntity: Name: NameFull: Lincoff, A.Michael – PersonEntity: Name: NameFull: Anderson, Keaven M. – PersonEntity: Name: NameFull: Achenbach, Robert – PersonEntity: Name: NameFull: Patel, Kamlesh – PersonEntity: Name: NameFull: Barnathan, Elliot – PersonEntity: Name: NameFull: Califf, Robert M. – PersonEntity: Name: NameFull: Topol, Eric J. – PersonEntity: Name: NameFull: EPIC Investigators – PersonEntity: Name: NameFull: EPILOG investigators – PersonEntity: Name: NameFull: EPISTENT investigators IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 09 Text: Sep2002 Type: published Y: 2002 Identifiers: – Type: issn-print Value: 00029149 Numbering: – Type: volume Value: 90 – Type: issue Value: 6 Titles: – TitleFull: American Journal of Cardiology Type: main |
| ResultId | 1 |